Image Credit: Health and me
There's been an alarming increase of respiratory and gastrointestinal viruses in the United States lately, causing anxiety about a so-called "quad-demic". According to surveillance reports, influenza, COVID-19, RSV and norovirus are at very high levels everywhere. While the surge aligns with patterns typical for this season, several epidemiologists view simultaneous infections of such proportions to pose risks not only to individual healthcare but public health.
The incidence of the quad-demic should vary with seasonal patterns, vaccination rates, and public health interventions. Each virus alone is relatively easy to manage; however, the effect of all together could lead to overburdening of health care facilities and increase risks for those at higher risk. Continuing surveillance, early testing, and proactive prevention measures will play an important role in the control of these infections going forward.
While the term "quad-demic" sounds daunting, it must be taken into perspective. For years, we have had all these viruses together, and we have the capabilities to mitigate some of the risk. Vaccination, proper hygiene and using common sense helps individuals get through the season unscathed. Is the quad-demic a permanent fixture or just another seasonal wave? Let's break this down.
Typically, flu, COVID-19, and RSV have been the primary culprits behind seasonal respiratory infections. However, norovirus, a highly contagious stomach bug, has emerged as a fourth significant player, inducing fears of a more severe and widespread viral outbreak. According to the Centers for Disease Control and Prevention (CDC), the U.S. recorded nearly 500 norovirus outbreaks between August and December 2023, a substantial rise from the previous year’s numbers.
While the term "quad-demic" may sound ominous, the seriousness and consequences of such infections should be weighed in light of the U.S. healthcare system's experience with managing viral surges since the start of the COVID-19 pandemic.
Flu continues to be one of the most common and alarming seasonal illnesses. In the period spanning from 2023 to 2024, there were approximately 40 million cases of flu, and thousands of hospitalizations along with reported 47 deaths have been reported this season. Flu symptoms include fever, chills, cough, sore throat, muscle pain, and fatigue, with most recovering within a week or two but risky factors for severe illness effects occur in young children, elderly, and people with chronic conditions.
Despite its reduction from the first pandemic peak, COVID-19 is still rampant. The CDC estimates that alone between October and December 2023, there were between 2.7 and 5 million cases in the U.S. Hospitalization has increased by cities such as Los Angeles, Chicago, and New York. Symptoms are closely similar to the flu, fever, cough, and fatigue but uniquely presents in some cases as loss of taste and smell.
RSV is the most common cause of lower respiratory infections in infants, older adults, and immunocompromised individuals. While RSV peaked late in 2023 and early 2024, it continues to be a threat because it can lead to bronchiolitis and pneumonia. It is very similar to the common cold, presenting with symptoms such as congestion, runny nose, coughing, and fever, which can make it difficult to differentiate from flu or COVID-19 without testing.
Norovirus, also called the "stomach flu," is a highly contagious infection of the gastrointestinal tract, not a respiratory virus. It transmits quickly from contaminated food and water and contact with contaminated surfaces, causing such symptoms as diarrhea, vomiting, nausea, and stomach pain. Cases have shot up, the CDC said Monday, with reports of outbreaks surging compared with last year.
The greatest challenge during the quad-demic is how the four viruses are alike and thus make identification very hard with no testing applied. Most cases present symptoms common to all viruses: fever, tiredness, body pains, and respiratory, which includes coughing and congestions for influenza, COVID-19, and RSV; the other would be norovirus symptoms as nausea and vomiting can appear even in extreme influenza and COVID-19. This overlap increases the risk of misdiagnosis and delayed treatment, hence the need for early testing and proper medical guidance.
Also Read: Is US Preparing For A Quad- demic 2025?
The best defense against these viruses is a combination of vaccines, hygiene, and lifestyle precautions. While lifestyle modifications are highlighted as part of the constant need to eat healthy, ensure daily movement and drinking adequate amount of fluids. There is a sure short two preventive strategies that are effective:
While debates on masked wear continue on, experts on mask-wear affirm that this does not only have a historical precedent but works towards reducing airborne viruses spreading within the environments. Hospitals, though, ensure masking in key sections of themselves. Publicized mask-wear remains a discretion, though massing indoors still goes a longer way in cases like peak flu seasons.
If you notice the symptoms of these viruses, then it's best to be confined at home and avoid having face-to-face interaction with others and seek immediate attention from your physician if your condition worsens. Quarantining for some days can decrease the spread of infection.
As we move into the first half of 2025 and beyond, staying informed and proactive is the best strategy for maintaining health and avoiding unnecessary panic. The key takeaway? Stay vigilant, but don’t be alarmed—these viruses are here, but so are the means to fight them.
Credit: PIB
President Droupadi Murmu has urged popular film artists not to endorse products that are harmful to health, highlighting their influence on children and young people.
Speaking at the 72nd National Film Awards in Kevadia, Gujarat, the President said successful film artists can influence the choices and habits of millions of young people.
“When successful film artists speak about the benefits of a disciplined lifestyle, millions of children and young people emulate them,” she said.
“I would like to request that popular artists refrain from endorsing substances that are harmful to health,” she added, saying that “a true star is one who spreads light, not darkness”.
The President’s remarks come amid concerns over the influence of celebrity and influencer marketing on health choices, particularly among younger audiences.
Dr Ambrish Mithal, Chairman, Endocrinology and Diabetes, Max HealthCare, welcomed the message.
“There could not be a better message than this- many thanks to our President for saying it out clearly. The impact of such advertising on the minds of the youth is huge. I hope her appeal makes our film stars and sportspersons realise the harm they could be causing. At the same time, discouraging the sale of such products by deterrents for manufacturers and advertisers is much needed,” he said in a post on X.
The issue has also come into focus amid controversies over celebrity endorsements of ultra-processed foods and pan masala-linked products. The Maharashtra Food and Drug Administration issued show-cause notices to Shah Rukh Khan, Ajay Devgn and Tiger Shroff over their appearance in a Vimal Elaichi advertisement.
Doctors Seek Curbs On Junk Food Ads
The concerns extend beyond pan masala-linked products to foods and beverages high in fat, salt and sugar, particularly those marketed to children and families.
In August, a group of doctors, medical scientists and public health experts brought together by Nutrition Advocacy in Public Interest-India (NAPi) urged the government to restrict advertising of foods high in fat, salt and sugar (HFSS), as well as ultra-processed foods.
In a representation to Union Health Minister J P Nadda, the experts called for restrictions on HFSS and ultra-processed food advertising between 6 am and 11 pm across television, print, digital, streaming and social media.
They also sought mandatory front-of-pack warning labels identifying products high in sugar, salt or fat, along with restrictions on marketing practices aimed at children and families.
The calls for tighter scrutiny of food marketing come amid rising overweight and obesity levels among Indian adults.
According to NFHS-6 (2023-24), 30.7% of women and 27.3% of men aged 15-49 years were overweight or obese, up from 24% and 22.9%, respectively, in NFHS-5 (2019-21).
NFHS-6 also recorded an increase in high or very high blood sugar, or the use of medication to control blood sugar, among adults aged 15 years and above. The proportion rose from 13.5% to 17.8% among women and from 15.6% to 20.9% among men between NFHS-5 and NFHS-6.
Data from World Obesity Atlas, more than 41 million children aged 5 to 19 in India suffer from high BMI (including 14 million living strictly with obesity).
Adding to the scrutiny around food marketing, the Food Safety and Standards Authority of India (FSSAI) last month cautioned celebrities and social media influencers against promoting misleading or unverified food claims.
FSSAI has warned that promoting misleading or unverified food claims can attract legal consequences.
Credit: AI
Kratom is a plant-based product sometimes used as a natural way to boost energy, manage pain or ease opioid withdrawal. It is is showing up frequently among patients in addiction clinics across the US.
According to STAT, at Boulder Care, a telehealth addiction clinic, the number of new patients using kratom increased from 3% in September 2025 to 8% in July 2026, before reaching 14% in August.
Clinicians say the growing problem is not only traditional kratom leaf. Increasingly, patients are using products containing high concentrations of 7-hydroxymitragynine, or 7-OH, a potent compound associated with opioid-like effects.
Dr Ayesha Appa, head of medical affairs at Boulder Care described "the increase as quite an explosion.”
Kratom is made from the leaves of the Mitragyna speciosa tree, which is found in Southeast Asia. The leaves have traditionally been used for their stimulant and pain-relieving effects. They are now sold in the US as powders, capsules, teas, extracts and other products.
At lower doses, kratom can produce stimulant-like effects, including increased alertness and energy. At higher doses, its effects can become more sedating and produce opioid-like effects.
The plant's main alkaloid is mitragynine. Another compound, 7-OH, occurs naturally in trace amounts in kratom leaf.
Kratom can interact with opioid receptors in the brain, which are involved in pain, reward and dependence. Regular use can therefore make the brain adapt to the substance.
When someone who has developed dependence suddenly stops taking it, withdrawal symptoms can occur, like irritability, restlessness, muscle aches, fatigue, sweating and other flu-like symptoms.
The FDA says epidemiological evidence suggests that some people develop substance use disorder after using kratom, although it also notes that the abuse potential of kratom has not been fully characterised in well-designed human studies.
Also read: Warning Letter Sent To Companies Selling Illegal Opioid Compound
7-OH is different from the small amounts naturally present in ordinary kratom leaf. Some products now sold as kratom contain concentrated 7-OH, including tablets, gummies, drink shots and other products.
The FDA describes these products as potent opioids, warning that they have not been proven safe or effective for any medical use.
The American College of Medical Toxicology says clinical experience has linked 7-OH with opioid-like effects, including intoxication, respiratory depression, dependence and withdrawal.
CDC data show that kratom-related poison-center reports increased dramatically over the past decade. US poison centers recorded 3,434 kratom exposure reports in 2025, compared with 258 in 2015, an approximately 1,200% increase. Hospitalisations following single-substance kratom exposures also rose from 43 in 2015 to 538 in 2025.
The shift toward concentrated products is another concern. Poison Centers reported 901 exposures involving 7-OH between January and June 2026, compared with 593 during all of 2025.
Traditional kratom leaf contains a mixture of naturally occurring alkaloids, including mitragynine and small amounts of 7-OH. Commercial 7-OH products can contain far higher concentrations of the compound.
The stronger products may produce more pronounced opioid-like effects and carry greater risks of dependence and withdrawal.
Kratom is also not an FDA-approved treatment for pain, opioid withdrawal or any other medical condition. Its long-term effects remain vague.
Credit: AI
The US measles outbreak is showing no signs of slowing down as it has reached new locations. A new case was recently reported in Wisconsin's Chippewa County, outside the state's main southwestern outbreak area, while Philadelphia health officials are warning of a possible measles exposure at the city's international airport.
The developments are crucial as measles cases continue to increase across the US, with Pennsylvania reporting hundreds of cases and Wisconsin recording 171 confirmed cases so far in 2026.
Wisconsin's Department of Health Services confirmed one measles case in Chippewa County on September 22. According to reports, the case has been attributed to out-of-state travel.
It means that it may not be connected to southwestern Wisconsin outbreak, where cases are concentrated. The state said no public exposure sites have been identified so far. The Chippewa County Health Department is working with the infected person and healthcare providers to identify anyone who may have been exposed.
“Measles is highly contagious, so confirming a case in our community is concerning,” Chippewa County Health Officer Brittnay Herrick said. “Our public health team is working closely with partners to identify potential exposures and ensure those affected have the information and guidance they need.”
Wisconsin has reported cases in Grant, Iowa, Lafayette, Marathon and Vernon counties since August. The state's largest cluster remains in southwestern Wisconsin, where 161 confirmed and six possible cases had been reported by September 18.
On the other hand, Philadelphia health officials are also warning travelers about a separate possible measles exposure at Philadelphia International Airport. According to health officials, an infected person walked through Terminals B and F, as well as areas connecting to Terminals C, D and E, between 7:25 p.m. on September 13 and 12:05 a.m. on September 14.
The person remained inside the airport and did not leave the premises. Health officials said the airport exposure is not connected to a separate measles exposure reported recently at Children's Hospital of Philadelphia.
Philadelphia Health Commissioner Dr. Palak Raval-Nelson said, “This week's measles exposures are a reminder of how important it is for all of us to be up to date on our vaccinations.” She added that fully vaccinated people are not at high risk from the suspected exposures.
People who were at the airport during the exposure period are being advised to check whether they are immune.
Those who are unvaccinated or unsure of their vaccination status, along with infants, pregnant people who are not immune and people with weakened immune systems, should contact a healthcare provider.
Also read: Debby Ryan Opens Up About ‘Life-Altering’ Brain Injury And ‘Hellish’ Migraines That Followed
Measles is among the most contagious infectious diseases. The virus spreads through the air when an infected person coughs, sneezes or breathes, and can remain in the air for up to two hours after the person has left an area.
Early symptoms typically include fever, cough, runny nose and red, watery eyes, followed several days later by a characteristic rash. Serious complications can include pneumonia, brain inflammation and, in some cases, death.
The Philadelphia Health Department says measles can be transmitted from four days before through four days after the rash appears, meaning an infected person can spread the virus before realizing they have measles.
People who may have been exposed should first find out if they are immune. Two documented doses of the MMR vaccine provide strong protection against measles. People who are not immune may be eligible for post-exposure treatment, depending on when the exposure happened.
© $2026 Times Horizon Private Limited